ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Design and Characterization of a Novel eEF2K Degrader with Potent Therapeutic Efficacy Against Triple-Negative Breast Cancer.

Changxin Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.